Media Coverage

Dr. Raphael Hofstein in Biotechnology Focus: It’s time to declare an end to Canada’s two research solitudes

Biotechnology Focus, a compendium of the Canadian life sciences industry, has published a guest column by Dr. Raphael Hofstein, MaRS Innovation's president & CEO, and Elizabeth Monier-Williams, director of marketing and communications. The article explores the way research focused on discovery and commercialization are often viewed or positioned as competitors within the funding ecosystem and the need to align their goals: The time of Canada’s French and English solitudes may be past, as Governor General Michaëlle Jean notably stated when she took office ... Read more

LegWorks developing better, more affordable prosthetic knees for developing world

TORONTO (May 27, 2015)  – LegWorks Inc., backed with a $2 million blend of private and Government of Canada investments catalyzed by Grand Challenges Canada, is a new Toronto-based company that will contribute to a better life for amputees in developing countries. The LegWorks AT-knee was covered in the Toronto Star on June 1, 2015 in "Great advances being made in assistive technology" by Kate Allen and in Healio Orthotics & Prosthetics News on June 2. The LegWorks “All-Terrain Knee” (AT-Knee) is a ... Read more

Onyx Motion’s digital coach Swish featured on Canada AM

UTEST company Onyx Motion's lead product, Swish -- a basketball virtual coach that currently works with Android Wear smartwatches to help basketball athletes to improve their shooting technique and emulate their heroes -- was featured on Canada AM this morning. Watch the clip of Onyx Motion's Swish on Canada AM, CTV's flagship morning show. Product feature plays after advertisements and begins at 1:40 mark. Think you've got an equally great software-based idea for a start-up? UTEST is currently recruiting for its fourth cohort. Tom ... Read more

Globe and Mail features UTEST company eQOL’s home dialysis technology

"When Binh Nguyen, then a graduate student in biomedical engineering at the University of Toronto, was working in the renal engineering department of a local hospital, he was struck by what he felt was a suboptimal setup for dialysis treatment," writes Jordana Dixon in "Health startup helps patients become more independent," for the Globe and Mail on April 13, 2015. eQOL Inc. is a University of Toronto and MaRS Innovation start-up company that participated in and graduated from the University of Toronto ... Read more

Smartphones and mobile tablets becoming mainstays for clinicians

VitalHub's partnership with Microsoft and Intel for Seattle Children's Hospital pilot and British Columbia contracts featured in Canadian Healthcare Technology "As hospital invest continue to invest in mobile solutions, doctors and nurses are more likely to be texting on their smartphones or swiping their fingers across a tablet PCs than tapping away on desktop computers," Dianne Daniel writes in the April 2015 issue of Canadian Healthcare Technology in an article titled, "Smartphones and mobile tablets are becoming essential tools for clinicians" ... Read more

UTEST company Nvest is bringing accountability to investment recommendations

Nvest, a University of Toronto company, is gaining traction as a financial technology (or fintech) start-up to watch. Nvest is part of the third UTEST cohort, which is an early-stage technology incubator program co-directed by MaRS Innovation and U of T (read more about the UTEST program in our portfolio section). In the last month, Nvest has been profiled in both TechVibes and Investment Executive as a company to watch both as a social network for stock picking and as a tool ... Read more

ChipCare closes oversubscribed $5 million series A financing

With lead investment from Puffin Partners, the Ontario, Canada-based company is taking lifesaving blood-testing technology to low- and middle-income countries TORONTO, March 3, 2015 — ChipCare Corporation, a University of Toronto start-up company commercializing a handheld, blood-testing platform for HIV and other infectious and non-communicable diseases has closed a $5.045 million Series A financing to bring its first-generation product to market while further developing the platform’s next generation products. The Wall Street Journal's Venture Capital Dispatch blog, Yonge Street Media, BetaKit and PEHub ... Read more

Portfolio round-up: UTEST, Nvest and Whirlscape news

Sometimes there's so much happening with the MaRS Innovation portfolio that it's hard to stay on top of all the news. Here are a few UTEST program stories that we missed in February. UTEST was named to FundThrough.com's list of "6 Exciting Canadian Startup Accelerators to Watch in 2015." Program co-directors Mike Betts and Kurtis Scissons point out that UTEST does take an equity position in the incubated companies and does not run on a grant basis as mentioned in the ... Read more

Ontario government announces over $400,000 for eQOL’s home dialysis technology

SAULT STE. MARIE, February 13, 2015  — eQOL, a Sault Ste. Marie-based company working to enhance patient independence and a graduate of the second University of Toronto Early-Stage Technology (UTEST) incubator's second cohort, has received $435,475 from the Ontario Government. David Orazietti, MPP for Sault Ste. Marie, made the announcement on February 13, 2015. This announcement was covered by BetaKit, The Sault Star and SooToday.com. The funding, which includes $415,000 through the Northern Ontario Heritage Fund Corporation (NOHFC) and $20,475 to hire an ... Read more

BioCentury features ScarX Therapeutics as emerging company

ScarX Therapeutics, a MaRS Innovation start-up company from the Hospital for Sick Children, was featured in "Scars Defaced," a BioCentury emerging company profile by Michael J. Haas. The profile is available to BioCentury subscribers on their website (paywall in place). Here's a short excerpt: ScarX Corp. has reformulated a generic analgesic that is marketed primarily in Europe into a topical cream that patients can self-administer after surgery to prevent scarring. The company expects cosmetic and reconstructive surgeons to be early adopters of its topical nefopam, ... Read more
Page 5 of 19« First...34567...10...Last »